GSK Shopper Healthcare is being rebranded globally as Haleon, pronounced “hay-lee-on,” and can be demerged from guardian GSK by mid 2022.

The brand new identify comes from a mash-up of the phrases “hale” and “leon,” merging good well being with energy, and it was all carried out with assist from staff and customers — no less than that they had the sense to place some vowels in it, in contrast to a variety of current rebrands. There’s no point out of a branding company however presumably one was concerned alongside the road.

GSK’s shopper healthcare division, which rejected a £50bn bid from Unilever final month, made an working revenue of £2.2bn in 2021. Its manufacturers, which deal with oral well being, ache reduction and nutritional vitamins, embrace Aquafresh, Sensodyne, Panadol, Advil, and Centrum.

Haleon CEO designate Brian McNamara mentioned: “Introducing Haleon to the world marks one other step in our journey to turn out to be a brand new, standalone firm. Our identify is grounded in our objective to ship higher on a regular basis well being with humanity and to be a world-leader in shopper healthcare. We’re on observe to launch Haleon in mid-2022 and our enterprise momentum is robust.”

Dave Lewis, former CEO of Tesco, was made non exec chair of Haleon in December, quickly after the enterprise introduced its transfer from West London to Weybridge in Surrey, additionally residence to P&G.